Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Pathology|August 18, 2019
Myeloid-Derived Lymphatic Endothelial Cell Progenitors Significantly Contribute to Lymphatic Metastasis in Clinical Breast CancerLisa Volk-Draper, Radhika Patel, Nihit Bhattarai, et al.
The Journal of Investigative Dermatology|April 9, 2025
Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti-PD-1 Therapy in NRAS-Mutant MelanomaLiya Su, Dinghao Wang, Timothy J Purwin, et al.
International Journal of Cancer|October 2, 2009
Tumor suppressor function of Rab25 in triple-negative breast cancerJi-Ming Cheng, Lisa Volk, Deepak Kumar Mummidavarapu Janaki, et al.
Lymphatic Research and Biology|October 13, 2006
Molecular profile and proliferative responses of rat lymphatic endothelial cells in cultureBrandt Whitehurst, Chad Eversgerd, Michael Flister, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2019
Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomyBradley C Holland, Akshay Sood, Kristin Delfino, et al.
Neoplasia (New York, N.Y.)|June 3, 2008
Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapyLisa D Volk, Michael J Flister, Christopher M Bivens, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumorsLiesbeth M Veenendaal, Hangqing Jin, Sophia Ran, et al.
Immunology and Cell Biology|December 24, 2014
IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned mediaErica Maria Pimenta, Saurav De, Ryan Weiss, et al.
Head & Neck|March 25, 2009
Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neckOhad Ronen, James P Malone, Paul Kay, et al.
Molecular Cancer Research : MCR|January 11, 2012
WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathwayShin Yoshioka, Mandy L King, Sophia Ran, et al.
Pageof 6